P. Debourdeau

Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial

J. Guigay, Anne Aupérin, Jérôme Fayette et al. · The Lancet Oncology · 2021 · 232 citations

Medicine, Oncology, Chemotherapy +14

Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial

Renato D. Lópes, Celestia S. Higano, Susan F. Slovin et al. · Circulation · 2021 · 143 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +13

Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short-term prognosis

Sam Schulman, Michelle Zondag, Lori‐Ann Linkins et al. · Journal of Thrombosis and Haemostasis · 2015 · 104 citations · Full text

Medicine, Hematology, Oncology +14

Influence of the delay of adjuvant postoperative radiation therapy on relapse and survival in oropharyngeal and hypopharyngeal cancers

Laurent Bastit, Emmanuel Blot, P. Debourdeau et al. · International Journal of Radiation Oncology*Biology*Physics · 2001 · 60 citations

Medicine, Oncology, Radiation Oncology +13

Clinical Presentation and Short- and Long-term Outcomes in Patients With Isolated Distal Deep Vein Thrombosis vs Proximal Deep Vein Thrombosis in the RIETE Registry

Behnood Bikdeli, César Caraballo, Javier Trujillo‐Santos et al. · JAMA Cardiology · 2022 · 59 citations · Full text

Medicine, Hematology, Surgery +15